Stay updated on Cetuximab & Nivolumab in Head & Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Cetuximab & Nivolumab in Head & Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cetuximab & Nivolumab in Head & Neck Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Added sponsor context and a direct access point to related resources by introducing the Moffitt Cancer Center Clinical Trials website and sponsor name. A 'Helpful Links Provided by' label now appears to guide users to additional resources.
    Difference
    0.1%
    Check dated 2026-07-07T05:53:08.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.0 to v3.6.3, indicating a newer published version of the study details page. This reflects an update in the revision history (likely content or metadata changes) rather than a visible change to the page's substantive content.
    Difference
    0.0%
    Check dated 2026-06-30T00:36:33.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Recruitment status now indicates enrollment is closed. The page adds new helper sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment header and revision label to v3.6.0, replacing the prior heading and v3.5.5 reference.
    Difference
    0.4%
    Check dated 2026-06-15T19:59:48.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    A new site revision label v3.5.5 has been added, replacing the previous v3.5.4. This update reflects a minor platform release and does not modify the study content or user-facing information.
    Difference
    0.0%
    Check dated 2026-06-08T16:38:18.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    Deleted sponsor/affiliate identifiers ('Moffitt Cancer Center Clinical Trials website' and 'H. Lee Moffitt Cancer Center and Research Institute') and the 'Helpful Links Provided by' heading, changing how institutional affiliation and sponsor-related resources are presented on the study page.
    Difference
    0.1%
    Check dated 2026-06-01T12:55:25.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    A new Publications entry has been added, documenting a 2026 Am J Clin Oncol article evaluating neutrophil-to-lymphocyte ratio in patients treated with cetuximab and nivolumab for recurrent/metastatic head and neck squamous cell carcinoma.
    Difference
    0.0%
    Check dated 2026-05-25T14:20:10.000Z thumbnail image

Stay in the know with updates to Cetuximab & Nivolumab in Head & Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cetuximab & Nivolumab in Head & Neck Cancer Clinical Trial page.